AI Science Tracker

Tranylcypromine shows in-vitro activity against Leishmania major

Institut Pasteur de Tunis; Université de Tunis El Manar · 12 Jan 2026 · medicine

Discovery

Tranylcypromine shows in-vitro activity against Leishmania major

The study experimentally tested the previously model-predicted drug tranylcypromine against L. major promastigotes and intracellular amastigotes. It reports IC50 values of 83.6 and 31.6 µg/mL, respectively, and macrophage CC50 of 282.3 µg/mL. These relatively high in-vitro concentrations do not establish achievable exposure, patient safety or clinical efficacy; human monoamine oxidase mechanism is not shown as the parasite target.

Technology: Prior machine-learning drug-repurposing pipeline (the present study is experimental validation)

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Primary full text reports promastigote and intracellular amastigote assays with dose responses and host-cell cytotoxicity.
  • Still unknown: Prior drug/species work, tolerability and mechanism remain unresolved; no clinical inference.
  • AI role: Study experimentally validates a model-prioritized repurposing candidate from earlier research.

Evidence sources: https://doi.org/10.3389/fmicb.2025.1756231

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 16 Nov 2026. Review scope: publisher primary full text; PubMed primary metadata/abstract. Material checked for the specific claims stated in the record..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.